Multiple Sclerosis Clinical Trials in Houston

Showing 421-440 of 517 trials

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

NCT02049164

The purpose of this study is to determine the effective dose or dose range of AR08 in the treatment of VMS in menopausal females.

Vasomotor Symptoms (VMS)

Arbor Pharmaceuticals, Inc.32 participantsStarted Jan 2014

San Diego, California, United States • Colorado Springs, Colorado, United States • Colorado Springs, Colorado, United States +12 more locations

COMPLETED< 1 mile

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

NCT01397747

The primary objective is to determine the sensitivity and specificity of the Exact Colorectal Cancer (CRC) screening test for colorectal cancer, using colonoscopy as the reference method. Lesions will be confirmed as malignant by histopathologic examination. The secondary objective is to compare the performance of the Exact CRC screening test to a commercially available FIT assay, both with respect to cancer and advanced adenoma. Lesions will be confirmed as malignant or precancerous by colonoscopy and histopathologic examination.

Colorectal NeoplasmsDigestive System DiseasesColonic Diseases+1 more

Exact Sciences Corporation12,776 participantsStarted Jun 2011

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +181 more locations

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Multiple Sclerosis Trials in Other Cities

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis

A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis

Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis

Safety Study for the Treatment of Abdominal Aortic Aneurysms

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities

Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis

To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors

A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Other Conditions in Houston